R
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Rhone Ma Holdings Bhd
KLSE:RHONEMA
Price:
0.7
MYR
0.72%
Market Closed
Market Cap:
154.9m
MYR
Relative Value
The Relative Value of one RHONEMA stock under the Base Case scenario is hidden MYR. Compared to the current market price of 0.7 MYR, Rhone Ma Holdings Bhd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RHONEMA Relative Value
HIDDEN
Multiples Across Competitors
RHONEMA Competitors Multiples
Rhone Ma Holdings Bhd Competitors
Rhone Ma Holdings Bhd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MY |
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
154.9m MYR | 0.7 | 11.8 | 5.7 | 6.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
990.8B USD | 15.2 | 48 | 32.3 | 34.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.6B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
286.4B CHF | 4.7 | 30.4 | 12.8 | 15 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
232.4B GBP | 5.5 | 34.2 | 16.3 | 23.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.9B CHF | 5.4 | 21.8 | 13.4 | 17.2 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
298.8B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.3 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.2B USD | 2.5 | 20.2 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 6.8 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
